Refractory Severe Esophagitis During Durvalumab Therapy in a Patient With Locally Advanced NSCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.10.153
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Severe Esophagitis in a Patient With Gastrointestinal Stromal Tumor Treated With Imatinib

Endoscopy
Gastroenterology
2009English

Durvalumab Extends OS in NSCLC

Cancer Discovery
Oncology
2018English

Bullous Pemphigoid Associated With Cemiplimab Therapy in a Patient With Locally Advanced Cutaneous Squamous Cell Carcinoma

JAAD Case Reports
Dermatology
2020English

Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Severe Cerebellar Syndrome Linked With Durvalumab

Journal of Neurology Research
2020English

Fludarabine Combined With Radiotherapy in Patients With Locally Advanced NSCLC Lung Carcinoma: A Phase I Study

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2012English

Peritumoral Radiomics Features Predict Distant Metastasis in Locally Advanced NSCLC

PLoS ONE
Multidisciplinary
2018English

Severe Proliferative Retinopathy in a Patient With Advanced Muscular Dystrophy

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2004English

Tracheoesophageal Fistula in a Patient With Advanced NSCLC Who Received Chemoradiotherapy and Ramucirumab

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy